Intuitive Surgical Inc.

Intuitive Surgical trades at a 56.8 P/E despite sitting at RSI 45—well below overbought territory—suggesting the market is pricing in substantial future growth rather than current excess. At $160B market cap with only 1.89% short interest, the stock lacks the contrarian compression setup that could trigger a squeeze, while the neutral RSI implies room to move in either direction without technical exhaustion. The valuation appears less stretched than the headline multiple might suggest, given the robotic surgery sector's secular tailwinds, though execution risk remains inherent to any premium-priced compounder trading nearly 57x earnings.